BioCentury
ARTICLE | Financial News

Regimmune completes venture financing

February 17, 2014 8:00 AM UTC

Regimmune Corp., Tokyo, Japan Business: Inflammation, Autoimmune, Transplant Date completed: 2/14/14 Type: Venture financing Raised: $9.2 million Investors: Japan Asia Investment; Nippon Venture Capit...